Showing 1 - 6 results of 6 for search 'W. De Spiegelaere', query time: 0.07s Refine Results
  1. 1
    Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART

    Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART by W. De Spiegelaere, M. Kiselinova, M.J. Buzon, E. Malatinkova, M. Lichterfeld, L. Vandekerckhove

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR

    O2 Cross-validation of HIV DNA assays to quantify different HIV-1 subtypes by ddPCR by S. Rutsaert, W. Trypsteen, C. Van Hecke, M.A. De Scheerder, M. Kiselinova, K. Vervisch, W. De Spiegelaere, L. Vandekerckhove

    Published 2016
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Integration site analysis of latently infected cell lines: evidence of ongoing replication

    Integration site analysis of latently infected cell lines: evidence of ongoing replication by J. Symons, S.R. Lewin, A. Chopra, E. Malantinkova, W. De Spiegelaere, S. Leary, D. Cooper, L. Vandekerckhove, S. Mallal, P. Cameron

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs

    Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs by S. Kinloch, E. Malatinkova, W. De Spiegelaere, P. Bonczkowsk, M. Kiselinova, K. Vervisch, W. Trypsteen, M. Johnson, D. de Looze, L. Vandekerckhove

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients

    O5 The expression profile of host restriction factors in different cohorts of HIV-1-infected patients by C. Van Hecke, E. Malatinkova, W. De Spiegelaere, M. Sips, K. Vervisch, C. Verhofstede, M. Johnson, S. Kinloch-de Loës, W. Trypsteen, L. Vandekerckhove

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial

    The CCR5-agonist maraviroc reverses HIV latency, results from ex vivo studies and a randomized placebo controlled clinical trial by J. Symons, S.F.L. van Lelyveld, W. de Spiegelaere, A.M.J. Wensing, J. Drylewicz, A.I.M. Hoepelman, P.U. Cameron, H. Lu, T. Mota, A.I. Dantanarayana, L. Vandekerckhove, S.R. Lewin, K. Tesselaar, M. Nijhuis

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: